Literature DB >> 9388201

The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5'-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons.

S Mummidi1, S S Ahuja, B L McDaniel, S K Ahuja.   

Abstract

Human CC chemokine receptor 5 (CCR5), mediates the activation of cells by the chemokines macrophage inflammatory protein-1alpha, macrophage inflammatory protein-1beta, and RANTES, and serves as a fusion cofactor for macrophage-tropic strains of human immunodeficiency virus type 1. To understand the molecular mechanisms that regulate human CCR5 gene expression, we initiated studies to determine its genomic and mRNA organization. Previous studies have identified a single CCR5 mRNA isoform whose open reading frame is intronless. We now report the following novel findings. 1) Complex alternative splicing and multiple transcription start sites give rise to several distinct CCR5 transcripts that differ in their 5'-untranslated regions (UTR). 2) The gene is organized into four exons and two introns. Exons 2 and 3 are not interrupted by an intron. Exon 4 and portions of exon 3 are shared by all isoforms. Exon 4 contains the open reading frame, 11 nucleotides of the 5'-UTR and the complete 3'-UTR. 3) The transcripts appear to be initiated from two distinct promoters: an upstream promoter (PU), upstream of exon 1, and a downstream promoter (PD), that includes the "intronic" region between exons 1 and 3. 4) PU and PD lacked the canonical TATA or CAAT motifs, and are AT-rich. 5) PD demonstrated strong constitutive promoter activity, whereas PU was a weak promoter in all three leukocyte cell environments tested (THP-1, Jurkat, and K562). 6) We provide evidence for polymorphisms in the noncoding sequences, including the regulatory regions and 5'-UTRs. The structure of CCR5 was strikingly reminiscent of the overall structure of other chemokine/chemoattractant receptors, underscoring an important evolutionarily conserved function for a prototypical gene structure. This is the first description of functional promoters for any CC chemokine receptor gene, and we speculate that the complex pattern of splicing events and dual promoter usage may function as a versatile mechanism to create diversity and flexibility in the regulation of CCR5 expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9388201     DOI: 10.1074/jbc.272.49.30662

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.

Authors:  E Gonzalez; M Bamshad; N Sato; S Mummidi; R Dhanda; G Catano; S Cabrera; M McBride; X H Cao; G Merrill; P O'Connell; D W Bowden; B I Freedman; S A Anderson; E A Walter; J S Evans; K T Stephan; R A Clark; S Tyagi; S S Ahuja; M J Dolan; S K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  A strong signature of balancing selection in the 5' cis-regulatory region of CCR5.

Authors:  Michael J Bamshad; Srinivas Mummidi; Enrique Gonzalez; Seema S Ahuja; Diane M Dunn; W Scott Watkins; Stephen Wooding; Anne C Stone; Lynn B Jorde; Robert B Weiss; Sunil K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

3.  CCR5Delta32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5Delta32 protective effects.

Authors:  Qingwen Jin; Lokesh Agrawal; L Meyer; R Tubiana; Ioannis Theodorou; Ghalib Alkhatib
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

Review 4.  Targeting CCR5 for anti-HIV research.

Authors:  W-G Gu; X-Q Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-11       Impact factor: 3.267

5.  Transcription factor GATA-1 potently represses the expression of the HIV-1 coreceptor CCR5 in human T cells and dendritic cells.

Authors:  Mark S Sundrud; Scott E Vancompernolle; Karla A Eger; Tullia C Bruno; Arun Subramaniam; Srinivas Mummidi; Sunil K Ahuja; Derya Unutmaz
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

6.  A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants.

Authors:  L G Kostrikis; A U Neumann; B Thomson; B T Korber; P McHardy; R Karanicolas; L Deutsch; Y Huang; J F Lew; K McIntosh; H Pollack; W Borkowsky; H M Spiegel; P Palumbo; J Oleske; A Bardeguez; K Luzuriaga; J Sullivan; S M Wolinsky; R A Koup; D D Ho; J P Moore
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Cloning and functional characterization of the human fractalkine receptor promoter regions.

Authors:  Alexandre Garin; Philippe Pellet; Philippe Deterre; Patrice Debré; Christophe Combadière
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

8.  Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African populations.

Authors:  Anabela C P Picton; Maria Paximadis; Caroline T Tiemessen
Journal:  Infect Genet Evol       Date:  2010-03-04       Impact factor: 3.342

9.  Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc.

Authors:  Olga Latinovic; Janaki Kuruppu; Charles Davis; Nhut Le; Alonso Heredia
Journal:  Clin Med Ther       Date:  2009

Review 10.  Genome-wide scans for footprints of natural selection.

Authors:  Taras K Oleksyk; Michael W Smith; Stephen J O'Brien
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-01-12       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.